A Small Virus to Deliver Small Antibodies: New Targeted Therapies Based on AAV Delivery of Nanobodies
Nanobodies are camelid-derived single-domain antibodies that present some advantages versus conventional antibodies, such as a smaller size, and higher tissue penetrability, stability, and hydrophilicity. Although nanobodies can be delivered as proteins, in vivo expression from adeno-associated vira...
Main Authors: | Noelia Silva-Pilipich, Cristian Smerdou, Lucía Vanrell |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/9/9/1956 |
Similar Items
-
Long-Term Systemic Expression of a Novel PD-1 Blocking Nanobody from an AAV Vector Provides Antitumor Activity without Toxicity
by: Noelia Silva-Pilipich, et al.
Published: (2020-12-01) -
Humoral immune response to AAV
by: Roberto eCalcedo, et al.
Published: (2013-10-01) -
Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry
by: Edward E. Large, et al.
Published: (2021-07-01) -
Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano)
by: Mélanie Demeules, et al.
Published: (2020-09-01) -
Characterization of AAV-Specific Affinity Ligands: Consequences for Vector Purification and Development Strategies
by: Mario Mietzsch, et al.
Published: (2020-12-01)